KLINICKÁ FARMAKOLOGIE A FARMACIE / Klin Farmakol Farm. 2025;39(2):96-102 / www.klinickafarmakologie.cz 102 PŘEHLEDOVÉ ČLÁNKY Stručný přehled farmakoterapie v paliativní medicíně – část první LITERATURA 1. Sepúlveda C, Marlin A, Yoshida T, et al. Palliative care: the World Health Organization’s global perspective. J Pain Symptom Manag. 2002;24(2):91‑96. 2. Stone MJ. Goals of care at the end of life. In: Baylor Univ Med Cent Proc. 2001;14(2):134‑137. 3. Wilcock A, Twycross R. Palliative Care Formulary. 8th ed. London: Pharm Press. 2024. 4. Franken LG, de Winter BC, van Gelder T, et al. Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidol. Expert Opin Drug Metab Toxicol. 2016;12(6):669‑680. 5. Jansen K, Haugen DF, Pontoppidan C, et al. Safety and effectiveness of palliative drug treatment in the last days of life – a systematic literature review. J Pain Symptom Manag. 2018;55(2):508‑521.e3. 6. Chillistone S, Hardman JG. Factors affecting drug absorption and distribution. Anaesth Intensive Care Med. 2017;18(7):335‑339. 7. Twycross R, Wilcock A, eds. Introducing Palliative Care. 5th ed. London: Pharm Press. 2016. 8. Cherny NI, Fallon M, Kaasa S, et al. Oxford Textbook of Palliative Medicine. 6th ed. Oxford: Oxford Univ Press. 2021. 9. Bruera E, Higginson IJ, von Gunten CF, et al. Textbook of Palliative Medicine and Supportive Care. 3rd ed. Boca Raton: CRC Press. 2021. 10. Van den Beuken-van MHJ, Hochstenbach LMJ, Joosten EAJ, et al. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manag. 2016;51(6):1070‑1090.e9. 11. Doth AH, Hansson PT, Jensen MP, et al. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain. 2010;149(2):338‑344. 12. Saunders CM. The management of terminal illness. 1967. 13. World Health Organization. Cancer Pain Relief. Geneva: WHO. 1986. 14. Anekar AA, Hendrix JM, Cascella M. WHO analgesic ladder. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024-5-29]. Available from: http://www. ncbi.nlm.nih.gov/books/NBK554435/. 15. Baldo BA. Opioid-induced respiratory depression: clinical aspects and pathophysiology of the respiratory network effects. Am J Physiol Lung Cell Mol Physiol. 2025;328(2):L267‑L289. 16. Karlic KJ, Frohlich T, Haas J, et al. Use of opioids for refractory dyspnoea in hospitalised patients with serious illness: a narrative review. Postgrad Med J. 2023;99(1169):139‑144. 17. Hicks CM, Dyck MA, Martin L, et al. Patient‑Controlled Analgesia for Managing Pain in Adults Receiving Palliative Care: A Scoping Review. Pain Manag Nurs. 2025;25(2):101‑204. 18. Fine PG, Portenoy RK, Adair D, et al. Establishing “best practices” for opioid rotation: conclusions of an expert panel. J Pain Symptom Manag. 2009;38(3):418‑425. 19. Mercadante S. Opioid combination: rationale and possible clinical applications. Ann Palliat Med. 2013;2(4):189‑196. 20. Zhong W, He Y, Wang X, et al. Mechanisms of nausea and vomiting: current knowledge and recent advances in intracellular emetic signaling systems. Int J Mol Sci. 2021;22(11):5797. 21. Wojtasik-Bakalarz K, Woroń J, Siwek M. Adverse effects of opioid analgesics from the central nervous system. Palliat Med Pract. 2021;15(3):241‑247. 22. Ben-Aharon I, Gafter-Gvili A, Paul M, et al. Interventions for alleviating cancer-related dyspnea: a systematic review. J Clin Oncol. 2008;26(14):2396‑2404. 23. Yamaguchi T, Kizawa Y, Maeda I, et al. Treatment Recommendation for Dyspnea in Patients with Advanced Disease: Revised Clinical Guidelines from the Japanese Society for Palliative Medicine. J Palliat Med. 2024;27(10):1404‑1414. 24. Luo N, Liu J, Huang L, et al. Efficacy and safety of opioids in treating cancer-related dyspnea: a systematic review and meta-analysis based on randomized controlled trials. J Pain Symptom Manag. 2021;61(1):198‑210.e1. 25. Ekström M, Bajwah S, Bland JM, et al. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review. Ann Am Thorac Soc. 2015;12(7):1079‑1092. 26. Cragg A, Hau JP, Woo SA, et al. Risk factors for misuse of prescribed opioids: a systematic review and meta-analysis. Ann Emerg Med. 2019;74(5):634‑646. 27. Dalal S, Bruera E. Pain management for patients with advanced cancer in the opioid epidemic era. In: Am Soc Clin Oncol Educ Book. 2019;39:24‑35. PŘÍLOHY K ČLÁNKU 1 Deník bolesti 2 P oučení pro pacienty užívající transdermální opioidy 3 P oučení pro pacienty užívající perorální opioidy ke stažení ZDE:
RkJQdWJsaXNoZXIy NDA4Mjc=